Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CTSO NASDAQ:EDAP NASDAQ:MBOT NASDAQ:SNWV On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCTSOCytosorbents$0.60-0.9%$0.65$0.50▼$1.39$37.87M1.4378,491 shs27,641 shsEDAPEdap Tms$4.25+2.0%$3.72$1.21▼$5.05$159.10M-0.157,640 shs32,068 shsMBOTMicrobot Medical$2.12-0.7%$2.41$1.60▼$4.67$142.04M1.061.81 million shs395,285 shsSNWVSanuwave Health$15.95-4.2%$19.68$15.35▼$46.58$137.51M1.3771,038 shs9,363 shs7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCTSOCytosorbents+6.93%-0.08%-0.07%-9.30%-30.97%EDAPEdap Tms+15.56%+25.30%+22.35%-12.05%+80.87%MBOTMicrobot Medical-2.74%+1.91%-6.99%+21.02%-15.14%SNWVSanuwave Health+4.59%+1.71%+0.60%-35.54%-47.38%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCTSOCytosorbents$0.60-0.9%$0.65$0.50▼$1.39$37.87M1.4378,491 shs27,641 shsEDAPEdap Tms$4.25+2.0%$3.72$1.21▼$5.05$159.10M-0.157,640 shs32,068 shsMBOTMicrobot Medical$2.12-0.7%$2.41$1.60▼$4.67$142.04M1.061.81 million shs395,285 shsSNWVSanuwave Health$15.95-4.2%$19.68$15.35▼$46.58$137.51M1.3771,038 shs9,363 shs7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCTSOCytosorbents+6.93%-0.08%-0.07%-9.30%-30.97%EDAPEdap Tms+15.56%+25.30%+22.35%-12.05%+80.87%MBOTMicrobot Medical-2.74%+1.91%-6.99%+21.02%-15.14%SNWVSanuwave Health+4.59%+1.71%+0.60%-35.54%-47.38%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCTSOCytosorbents 2.00Hold$5.38789.90% UpsideEDAPEdap Tms 2.00Hold$6.0041.34% UpsideMBOTMicrobot Medical 2.60Moderate Buy$7.50254.61% UpsideSNWVSanuwave Health 2.50Moderate Buy$51.00219.75% UpsideCurrent Analyst Ratings BreakdownLatest CTSO, MBOT, SNWV, and EDAP Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/14/2026MBOTMicrobot Medical HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$12.004/10/2026MBOTMicrobot Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)4/9/2026EDAPEdap Tms HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$14.00 ➝ $10.004/8/2026CTSOCytosorbents Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)3/30/2026SNWVSanuwave Health Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell3/30/2026SNWVSanuwave Health Roth MkmSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$53.00 ➝ $47.003/27/2026SNWVSanuwave Health Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (D-) ➝ Hold (C-)3/26/2026CTSOCytosorbents D. Boral CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$10.002/10/2026MBOTMicrobot Medical B. Riley FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy2/10/2026MBOTMicrobot Medical B. Riley FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$5.002/9/2026MBOTMicrobot Medical B. Riley FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy(Data available from 5/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCTSOCytosorbents$37.06M1.02N/AN/A$0.09 per share6.71EDAPEdap Tms$70.53M2.26N/AN/A$0.52 per share8.16MBOTMicrobot MedicalN/AN/AN/AN/A$1.15 per shareN/ASNWVSanuwave Health$44.05M3.11$1.70 per share9.38$0.19 per share83.95Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCTSOCytosorbents-$8.20M-$0.13N/AN/AN/A-22.12%-150.53%-32.75%5/13/2026 (Estimated)EDAPEdap Tms-$29.25M-$0.77N/AN/AN/A-41.24%-100.07%-37.38%N/AMBOTMicrobot Medical-$13.14M-$0.29N/AN/AN/AN/A-24.44%-23.12%5/13/2026 (Estimated)SNWVSanuwave Health$11.81M-$0.16N/A16.79N/A26.64%-141.56%34.53%5/8/2026 (Estimated)Latest CTSO, MBOT, SNWV, and EDAP EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2026Q1 2026CTSOCytosorbents-$0.06N/AN/AN/A$9.40 millionN/A5/13/2026N/AMBOTMicrobot Medical-$0.08N/AN/AN/A$0.30 millionN/A5/8/2026Q1 2026SNWVSanuwave Health-$0.05N/AN/AN/A$9.65 millionN/A3/27/2026Q4 2025MBOTMicrobot Medical-$0.06-$0.04+$0.02-$0.04$0.11 millionN/A3/26/2026Q4 2025EDAPEdap Tms-$0.16-$0.25-$0.09-$0.26$21.28 million$18.94 million3/26/2026Q4 2025SNWVSanuwave Health$0.17$0.03-$0.14$0.6360$13.23 million$13.09 million3/25/2026Q4 2025CTSOCytosorbents-$0.05-$0.09-$0.04-$0.09$9.22 million$9.23 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCTSOCytosorbentsN/AN/AN/AN/AN/AEDAPEdap TmsN/AN/AN/AN/AN/AMBOTMicrobot MedicalN/AN/AN/AN/AN/ASNWVSanuwave HealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCTSOCytosorbents2.822.131.58EDAPEdap Tms0.841.541.19MBOTMicrobot MedicalN/A23.3323.16SNWVSanuwave Health10.081.381.05Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCTSOCytosorbents32.87%EDAPEdap Tms62.74%MBOTMicrobot Medical16.30%SNWVSanuwave Health42.53%Insider OwnershipCompanyInsider OwnershipCTSOCytosorbents7.30%EDAPEdap Tms0.23%MBOTMicrobot Medical4.74%SNWVSanuwave Health14.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCTSOCytosorbents22062.70 million58.12 millionOptionableEDAPEdap Tms23037.48 million37.40 millionOptionableMBOTMicrobot Medical2067.16 million63.98 millionOptionableSNWVSanuwave Health408.60 million7.32 millionN/ACTSO, MBOT, SNWV, and EDAP HeadlinesRecent News About These CompaniesSanuwave Will Host a Conference Call on May 13, 2026 at 8:30 AM (ET) to Present Q1 2026 Financial ResultsMay 6 at 5:00 PM | globenewswire.comSanuwave Health Inc. (SNWV) May Report Negative Earnings: Know the Trend Ahead of Q1 ReleaseMay 1, 2026 | zacks.comSanuwave Health (SNWV) Expected to Announce Earnings on FridayMay 1, 2026 | marketbeat.comHow The SANUWAVE Health (SNWV) Story Is Shifting After The Latest Price Target ResetApril 27, 2026 | finance.yahoo.comSanuwave Health Posts Record Results Amid CMS ShockApril 21, 2026 | theglobeandmail.comAnalysts Set Expectations for Sanuwave Health Q1 EarningsApril 21, 2026 | marketbeat.comSanuwave Health (SNWV) Slipped as CMS Dropped the Coverage LimitApril 20, 2026 | insidermonkey.comSanuwave Health Reports Preliminary Q1 2026 Revenue of $9.6–$9.7 Million, Up 3-4% Year-over-YearApril 16, 2026 | finance.yahoo.comHow The SANUWAVE Health (SNWV) Investment Narrative Is Resetting After A Lower Price TargetApril 13, 2026 | finance.yahoo.comSANUWAVE Health Inc (SNWV) Shares Fall 7.2% -- GF Value Says Still OvervaluedApril 11, 2026 | gurufocus.comSANUWAVE Health (SNWV) price target decreased by 19.44% to 44.37April 9, 2026 | msn.comHow The Reset Price Target Is Rewriting The Story For SANUWAVE Health (SNWV)March 29, 2026 | finance.yahoo.comSANUWAVE Health, Inc. (SNWV) Q4 2025 Earnings Call TranscriptMarch 27, 2026 | seekingalpha.comSANUWAVE Health, Inc.: Sanuwave Announces Record Revenues and Financial Results for Q4 and Full Year 2025March 27, 2026 | finanznachrichten.deSanuwave Announces Record Revenues and Financial Results for Q4 and Full Year 2025March 26, 2026 | globenewswire.comSANUWAVE Health Inc (SNWV) Q4 2025 Earnings Report Preview: What To Look ForMarch 26, 2026 | finance.yahoo.comSanuwave Will Host a Conference Call on March 27, 2026 at 8:30 AM (ET) to Present Q4 and Full Year 2025 Financial ResultsMarch 20, 2026 | globenewswire.comSANUWAVE Health (NASDAQ:SNWV) investors are sitting on a loss of 63% if they invested five years agoFebruary 10, 2026 | uk.finance.yahoo.comDeep Sail Capital Partners’ Investment Thesis for Sanuwave Health (SNWV)February 5, 2026 | insidermonkey.comSanuwave: A Compelling Asymmetric Opportunity In Advanced Wound CareJanuary 27, 2026 | seekingalpha.comSANUWAVE Health, Inc. (NASDAQ:SNWV) Has Found A Path To ProfitabilityJanuary 14, 2026 | uk.finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCTSO, MBOT, SNWV, and EDAP Company DescriptionsCytosorbents NASDAQ:CTSO$0.60 -0.01 (-0.90%) As of 11:06 AM Eastern This is a fair market value price provided by Massive. Learn more.Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology in the United States, Germany, and internationally. Its flagship product is CytoSorb, an extracorporeal cytokine adsorber for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention, and treatment of perioperative complications, and maintaining or enhancing the quality of solid organs harvested from donors for organ transplant; and offers VetResQ, a device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals. The company also develops CytoSorb-XL, a device for adjunctive therapy in the treatment of sepsis and other critical illnesses; HemoDefend blood purification technology platform to reduce contaminants in the blood supply that can cause transfusion reactions or disease when administering blood and blood products to patients, and removal of anti-A and anti-B blood group antibodies from whole blood and plasma; K+ontrol for treatment of severe hyperkalemia in patients with life-threatening conditions; and ContrastSorb for the removal of IV contrast in blood administered during CT imaging, an angiogram, or during a vascular interventional radiology procedure to reduce the risk of contrast-induced nephropathy. In addition, it develops BetaSorb, a device for the prevention and treatment of health complications caused by the accumulation of metabolic toxins in patients with chronic renal failure; DrugSorb, a device to remove drugs and chemicals from the blood; and DrugSorb-ATR, an antithrombotic removal system. The company was formerly known as MedaSorb Technologies Corporation and changed its name to Cytosorbents Corporation in May 2010. Cytosorbents Corporation was founded in 1997 and is headquartered in Princeton, New Jersey.Edap Tms NASDAQ:EDAP$4.24 +0.09 (+2.04%) As of 11:18 AM Eastern This is a fair market value price provided by Massive. Learn more.EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses on the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.Microbot Medical NASDAQ:MBOT$2.12 -0.02 (-0.70%) As of 11:22 AM Eastern This is a fair market value price provided by Massive. Learn more.Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.Sanuwave Health NASDAQ:SNWV$15.95 -0.70 (-4.20%) As of 11:22 AM Eastern This is a fair market value price provided by Massive. Learn more.SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Dutch Bros Q1 Earnings: The Newest Starbucks Rival Faces Its First Big Reality Check The AI Fear Around Datadog Stock May Have Been Completely Wrong Amprius Technologies Ups the Voltage on Forward Outlook Why Lam Research Still Looks Like a Buy After a 300% Rally Wells Fargo’s Comeback Is Real—But Not Risk-Free IonQ Just Posted a Breakout Quarter—But 1 Problem Remains SLB’s Tough Quarter Masks a Powerful Long-Term Shift Super Micro Surges Over 20% as Margins Soar, Sales Fall Short Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
